|
1
|
Raggatt LJ and Partridge NC: Cellular and
molecular mechanisms of bone modeling. J Biol Chem.
285:25103–25108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chambers TJ and Fuller K: How are
osteoclasts induced to resorb bone? Ann N Y Acad Sci. 1240:1–6.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Minguell JJ, Erices A and Conget P:
Mesenchymal stem cells. Exp Biol Med (Maywood). 226:507–520.
2001.PubMed/NCBI
|
|
4
|
Muruganandan S, Roman AA and Sinal CJ:
Adipocyte differentiation of bone marrow-derived mesenchymal stem
cells: Cross talk with the osteoblastogenesis program. Cell Mol
Life Sci. 66:236–253. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laudes M: Role of WNT signaling in the
determination of human mesenchymal stem cells into preadipocytes. J
Mol Endocrinol. 46:R65–R72. 2011.PubMed/NCBI
|
|
6
|
Gharibi B, Abraham AA, Ham J and Evans BA:
Adenosine receptor subtype expression and activation influence the
differentiation of mesenchymal stem cells to osteoblasts and
adipocytes. J Bone Miner Res. 26:2112–2124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawai M and Rosen CJ: PPARγ: A circadian
transcription factor in adipogenesis and osteogenesis. Nat Rev
Endocrinol. 6:629–636. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weitzmann MN and Pacifici R: Estrogen
deficiency and bone loss: An inflammatory tale. J Clin Invest.
116:1186–1194. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leslie WD, Rubin MR, Schwartz AV and Kanis
JA: Type 2 diabetes and bone. J Bone Miner Res. 27:2231–2237. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nielson CM, Srikanth P and Orwoll ES:
Obesity and fracture in men and women: An epidemiologic
perspective. J Bone Miner Res. 27:1–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gharibi B, Abraham AA, Ham J and Evans BA:
Adenosine receptor subtype expression and activation influence the
differentiation of mesenchymal stem cells to osteoblasts and
adipocytes. J Bone Miner Res. 26:2112–2124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pirih F, Lu J, Ye F, Bezouglaia O, Atti E,
Ascenzi MG, Tetradis S, Demer L, Aghaloo T and Tintut Y: Adverse
effects of hyperlipidemia on bone regeneration and strength. J Bone
Miner Res. 27:309–318. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Li A, Strait K, Zhang H, Nanes MS
and Weitzmann MN: Endogenous TNFalpha lowers maximum peak bone mass
and inhibits osteoblastic Smad activation through NF-kappaB. J Bone
Miner Res. 22:646–655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang J, Wang Z, Tang E, Fan Z, McCauley
L, Franceschi R, Guan K, Krebsbach PH and Wang CY: Inhibition of
osteoblastic bone formation by nuclear factor-kappaB. Nat Med.
15:682–689. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cortez M, Carmo LS, Rogero MM, Borelli P
and Fock RA: A high-fat diet increases IL-1, IL-6, and TNF-α
production by increasing NF-κB and attenuating PPAR-γ expression in
bone marrow mesenchymal stem cells. Inflammation. 36:379–386. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghelardini C, Galeotti N, Di Cesare
Mannelli L, Mazzanti G and Bartolini A: Local anaesthetic activity
of beta-caryophyllene. Farmaco. 56:387–389. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gertsch J, Leonti M, Raduner S, Racz I,
Chen JZ, Xie XQ, Altmann KH, Karsak M and Zimmer A:
Beta-caryophyllene is a dietary cannabinoid. Proc Nat Acad Sci USA.
105:9099–9104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ormeño E, Baldy V, Ballini C and Fernandez
C: Production and diversity of volatile terpenes from plants on
calcareous and siliceous soils: Effect of soil nutrients. J Chem
Ecol. 34:1219–1229. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katsuyama S, Mizoguchi H, Kuwahata H,
Komatsu T, Nagaoka K, Nakamura H, Bagetta G, Sakurada T and
Sakurada S: Involvement of peripheral cannabinoid and opioid
receptors in β-caryophyllene-induced antinociception. Eur J Pain.
17:664–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paula-Freile LI, Andersen ML, Gama VS,
Molska GR and Carlini EL: The oral administration of
trans-caryophyllene attenuates acute and chronic pain in mice.
Phytomedicine. 21:356–362. 2015. View Article : Google Scholar
|
|
21
|
Chavan MJ, Wakte PS and Shinde DB:
Analgestic and anti-inflammatory activity of caryophyllene oxide
from Annona squamosa L. Bark. Phytomedicine. 17:149–151. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martinez RM, Zarpelon AC, Cardoso RD,
Vicentini FT, Georgetti SR, Baracat MM, Andrel CC, Moreira IC,
Verri WA Jr and Casagrande R: Tephrosia sinapou ethyl acetate
extract inhibits inflammatory pain in mice: Opioid receptor
dependent inhibition of TNFα and IL-1β production. Pharm Biol.
51:1262–1271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamaguchi M, Weitzmann MN, Baile CA and
Murata T: Exogenous regucalcin suppresses osteoblastogenesis and
stimulates adipogenesis in mouse bone marrow culture. Integr Biol
(Camb). 4:1215–1222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamaguchi M, Zhu S, Zhang S, Wu D, Moore
TM, Snyder JP and Shoji M: Curcumin analogue UBS109 prevents bone
loss in breast cancer bone metastasis mouse model: Involvement in
osteoblastogenesis and osteoclastogenesis. Cell Tissue Res.
357:245–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Minkin C: Bone acid phosphatase:
Tartrate-resistant acid phosphatase as a marker of osteoclast
function. Calcif Tissue Int. 34:285–290. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zaidi M, Blair HC, Moonga BS, Abe E and
Huang CL: Osteoclastogenesis, bone resorption, and osteoblast-based
therapeutics. J Bone Miner Res. 18:599–609. 2003. View Article : Google Scholar : PubMed/NCBI
|
